BreviTest co-founder discusses technology that reduces diagnostic times

Share

Dr. Dev Chatterjee has developed an ultra–fast diagnostic device that can diagnose Ebola in the time it takes to brew coffee. Chatterjee, co-founder of BreviTest, takes a novel approach that re-imagines the immunoassay method as serial reactions in connected microfluidic chambers, which eliminates the traditional requirement of multiple washes to comprehensively remove residual reactants. BreviTest’s patent-pending technology has been reduced to practice with a prototype that successfully demonstrated completely automated ELISA reactions.

NEW! Technology Track at DeviceTalks Boston

textadimage These featured panels at DeviceTalks Boston will explore the state of R&D at major medtech firms, as well as the latest trends when it comes to developing combination products, neuromodulation devices, robotic systems and women's health technology.

View Technology Track Featured Sessions

Register today to save. Use code TECHTRACK to save an additional 10%.

Speak Your Mind

*